Nature 546 , 254258 (2017)
The vial of GLP-1 medication, an insulin syringe (29 to 31 gauge, 0.5mL or 1mL depending on your dose volume), alcohol swabs, a clean cotton ball or gauze pad, and a sharps container
Researchers study GLP-1 receptor agonists for their potential to reduce body weight , improve satiety , and help manage obesity and overweight conditions
Why would the body have GLP-1 receptors on our peripheral organs, if the hormone acts mainly through the vagus nerve
Payers and insurers are increasingly implementing restrictive coverage policies, such as limiting patient eligibility criteria, reducing prescription durations from 90 to 30 days, and favoring single-drug formularies to contain escalating costs
A costbenefit analysis based on real-world data on GLP-1 RA use in each Asian country, including Thailand, should be conducted